Pharmaceuticals
Drug use among older adults a 'hidden epidemic'
According to the International Narcotics Control Board, which recently issued its annual report, drug use among older adults is a 'hidden epidemic'. Dr Andy Towers from the School of Health Sciences… Audio
Piling on pressure for a costly ‘miracle’ drug
Last year Newshub put its weight behind a campaign to fund a treatment for cystic fibrosis from the public purse even though the cost was sky-high and the US-based maker never applied to register it… Audio
Piling on pressure for a costly ‘miracle’ drug
Last year Newshub put its weight behind a campaign to fund a treatment for cystic fibrosis from the public purse even though the cost was sky-high and the US-based maker never applied to register it…
AudioPrioritise lung cancer treatments, patients tell MPs
Lung cancer patients are launching a petition to push MPs to back more treatments at a drug funding review next month. Audio
Silos and sexism: addiction services and mental health
Despite addiction often being tied up with other mental health problems, treatment tends to be separate and siloed - and aimed primarily at men - author, journalist and former addict Jenny Valentish… Audio
Terminal cancer patients frustrated at lack of funded drugs
In some cases, women are having to raise hundreds of thousands of dollars themselves for treatments like Abrazane and Kacyla - both which have been publically funded in Australia for years. Audio
Potential drug price hike could be a hard pill to swallow
New Zealand may have to swallow higher drug prices if it wants a trade deal with the United States.
Pharmac and its role in making drugs available
Science communication student Garrett Chin talks with doctors and a health economist about the challenges that Pharmac faces in buying drugs, and what happens when new but expensvie drugs become… Audio
Pharmac and its role in making drugs available
Science communication student Garrett Chin talks with doctors and a health economist about the challenges that Pharmac faces in buying drugs, and what happens when new but expensvie drugs become…
AudioAFT H1 loss in line with expectations
The drug maker, AFT Pharmaceuticals, has reported an increased first half loss in line with expectations as it spent more on research and development and marketing.
Wasted drugs: cost, safety and the environment
Pharmacists are pushing for a national disposal system for unused drugs, as an unknown quantity are ending up in the bin and down the toilet. Audio
Pharmac's drug-funding bonanza
ANALYSIS: A funding boost from the government and DHBs means Pharmac is spreading its pharmaceutical-buying wings, writes Karen Brown
The overdiagnosis epidemic
An Australian researcher says increasing numbers of healthy people are being unnecessarily labelled sick - potentially at the behest of drug companies. Writing in the Australian Prescriber Dr Ray… Audio
Patients left in lurch as Bayer pulls free anti-coagulant
Fifteen hundred patients with blood-related problems have been left in the lurch by a big pharmaceutical company pulling a free anti-coagulant drug.
GP concerned as Bayer pulls free anti-coagulant drug
Bayer Pharmaceuticals is defending its decision to pull a free anti-coagulent drug from fifteen hundred patients with blood problems. Audio
Patients left in lurch as Bayer pulls free anti-coagulant
Fifteen hundred patients with blood problems have been left in the lurch after a big pharmaceutical company stopped supplying them a free anti-coagulant drug. Audio
Call to axe targeted Nurofen in NZ
New Zealand needs to follow Australia and pull some Nurofen pain-relief products from the market, the Consumers' Institute says. Audio
Patents, Pills and the Press - Dr Thomas Owen
The role of patents and access to medicine is making headlines, as a TPP deal was reached in Atlanta this morning. One man who has been looking at the global campaign for access to medicines is Dr… Audio
Frail woman given regular dose of paracetamol
The Waikato District Health Board has been criticised over the way it administered paracetamol to a frail, elderly woman who subsequently died.
Impasse on medicines is final hurdle in TPP talks
Dr Erik Monasterio, of the University of Otago in Christchurch, has concerns about what any change could mean for New Zealand. Audio
